Weltman M - Search Results

1

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

Eslam M, Hashem AM, Leung R, Romero-Gomez M, Berg T, Dore GJ, Chan HL, Irving WL, Sheridan D, Abate ML, Adams LA, Mangia A, Weltman M, Bugianesi E, Spengler U, Shaker O, Fischer J, Mollison L, Cheng W, Powell E, Nattermann J, Riordan S, McLeod D, Armstrong NJ, Douglas MW, Liddle C, Booth DR, George J, Ahlenstiel G; International Hepatitis C Genetics Consortium (IHCGC). Eslam M, et al. Among authors: weltman m. Nat Commun. 2015 Mar 5;6:6422. doi: 10.1038/ncomms7422. Nat Commun. 2015. PMID: 25740255 Free PMC article.

2

Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

Weltman MD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM, Liddle C. Weltman MD, et al. J Viral Hepat. 1995;2(1):39-45. doi: 10.1111/j.1365-2893.1995.tb00070.x. J Viral Hepat. 1995. PMID: 7493293 Clinical Trial.

3

Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.

Brotodihardjo AE, Tait N, Weltman MD, Liddle C, Little JM, Farrell GC. Brotodihardjo AE, et al. Among authors: weltman md. Med J Aust. 1994 Oct 3;161(7):433-5. Med J Aust. 1994. PMID: 7935098

4

Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation.

Weltman MD, Farrell GC, Liddle C. Weltman MD, et al. Gastroenterology. 1996 Dec;111(6):1645-53. doi: 10.1016/s0016-5085(96)70028-8. Gastroenterology. 1996. PMID: 8942745

5

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.

Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Weltman MD, et al. Hepatology. 1998 Jan;27(1):128-33. doi: 10.1002/hep.510270121. Hepatology. 1998. PMID: 9425928

6

How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C?

Khan MH, Thomas L, Byth K, Kench J, Weltman M, George J, Liddle C, Farrell GC. Khan MH, et al. Among authors: weltman m. J Gastroenterol Hepatol. 1998 Apr;13(4):419-26. doi: 10.1111/j.1440-1746.1998.tb00657.x. J Gastroenterol Hepatol. 1998. PMID: 9641308

7

Which patients with hepatitis C develop liver complications?

Khan MH, Farrell GC, Byth K, Lin R, Weltman M, George J, Samarasinghe D, Kench J, Kaba S, Crewe E, Liddle C. Khan MH, et al. Among authors: weltman m. Hepatology. 2000 Feb;31(2):513-20. doi: 10.1002/hep.510310236. Hepatology. 2000. PMID: 10655279

8

Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study.

Dutta U, Byth K, Kench J, Khan MH, Coverdale SA, Weltman M, Lin R, Liddle C, Farrell GC. Dutta U, et al. Among authors: weltman m. Aust N Z J Med. 1999 Jun;29(3):300-7. doi: 10.1111/j.1445-5994.1999.tb00710.x. Aust N Z J Med. 1999. PMID: 10868491

9

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.

Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J. Chitturi S, et al. Among authors: weltman m. Hepatology. 2002 Feb;35(2):373-9. doi: 10.1053/jhep.2002.30692. Hepatology. 2002. PMID: 11826411

10

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.

Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C, Samarasinghe D, Lin R, Abeygunasekera S, George J. Chitturi S, et al. Among authors: weltman m. Hepatology. 2002 Jul;36(1):142-9. doi: 10.1053/jhep.2002.33892. Hepatology. 2002. PMID: 12085358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters